Your browser doesn't support javascript.
loading
Effect of docetaxel added to bicalutamide in Hormone-Naïve non-metastatic prostate cancer with rising PSA, a randomized clinical trial (SPCG-14).
Josefsson, Andreas; Jellvert, Åsa; Holmberg, Erik; Brasso, Klaus; Meidahl Petersen, Peter; Aaltomaa, Sirpa; Luukkaa, Marjaana; Verhagen, Paul; de Wit, Ronald; Ahlgren, Göran; Andrén, Ove; Castellanos, Enrique; Seke, Mihalj; Widmark, Anders; Damber, Jan-Erik.
Affiliation
  • Josefsson A; Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Jellvert Å; Wallenberg Center for Molecular Medicin, Umeå University, Umeå, Sweden.
  • Holmberg E; Department of Urology and Andrology, Institute of surgery and perioperative Sciences, Umeå University, Umeå, Sweden.
  • Brasso K; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Meidahl Petersen P; Region Västra Götaland, NU Hospital Group, Department of Surgery, Uddevalla, Sweden.
  • Aaltomaa S; Department of Oncology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Luukkaa M; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Verhagen P; Regional Cancer Centre West, Gothenburg, Sweden.
  • de Wit R; Copenhagen Prostate Cancer Center, Department of Urology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Ahlgren G; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Andrén O; Department of Urology, Kuopio University Hospital, Kuopio, Finland.
  • Castellanos E; Department of Oncology, Turku University Hospital, Turku, Finland.
  • Seke M; Department of Urology, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Widmark A; Department of Medical Oncology, Erasmus University Medical Centre Cancer Institute, Rotterdam, the Netherlands.
  • Damber JE; Department of Urology, Lund University, Skåne University Hospital, Sweden.
Acta Oncol ; 62(4): 372-380, 2023 Apr.
Article in En | MEDLINE | ID: mdl-37073813

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Clinical_trials / Prognostic_studies Limits: Humans / Male Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen Type of study: Clinical_trials / Prognostic_studies Limits: Humans / Male Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido